Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian

Jennifer Markarian


Articles
FDA Takes Actions to Prevent Drug Shortages
November 1, 2013

FDA releases a strategic plan and issues a proposed notification rule to improve prevention and resolution of drug shortage problems.

Using Plastic for Parenteral Containers
June 1, 2013

A Q&A with SCHOTT Pharmaceutical Systems and West Pharmaceutical Services

Facility Trends: Modularization and Single Use
May 1, 2013

BioPharm International spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.

FDA Investigates Med Prep Consulting for Contaminated Intravenous Solution
March 21, 2013

The New Jersey-licensed specialty pharmacy recalls magnesium sulfate products and halts all production operations.

Daiichi Sankyo Condemns Falsely-represented Product
March 8, 2013

Product sold online in Malaysia and Indonesia infringes on the company’s trademark.

Report Explores Future of Opioid Abuse-Resistant Formulations
February 21, 2013

A GBI Research report says the opioid market will be driven by development of new products and post-marketing studies designed to reduce abuse risk.

GSK Announces Fourth Quarter 2012 Results and 2013 Plans
February 7, 2013

Group sales were down, but R&D progress points to future growth.

US Pharmacopeial Convention Announces Revised Official Dates for Elemental Impurities Chapters
January 31, 2013

Two general chapters on elemental impurities? limits and procedures are to become official Feb. 1, 2013, with implementation proposed for May 1, 2014.

Rutgers University Research Center and Janssen Develop Continuous Manufacturing Process
January 17, 2013

Rutgers engineers constructed a direct compaction line in collaboration with Janssen.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here